Capricor Therapeutics, Inc. News: Capricor Therapeutics Announces Intent to File Biologics License Application for Full Approval of Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 04/27/23 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 04/07/23 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 02/23/23 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 02/23/23 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 02/15/23 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 02/15/23 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/06/23 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/05/23 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/05/23 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/05/23 | Statement of changes in beneficial ownership of securities |
|
1 |